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PRIMARY sclerosing cholangitis is a rare disease of unknown aetiology in which
progressive obliteration ofthe extrahepatic and often also the intrahepatic bile ducts
occurs. Delbet' is generally credited with the first case report in 1924 and there are
still only 100 cases in the literature.2 The association with ulcerative colitis is well
known.3 We report twelve cases of primary sclerosing cholangitis seen and followed
up at the Royal Victoria Hospital during an eighteen-year period (1964-1982).
DEFINITIONS
The term 'primary sclerosing cholangitis' is used to describe non-traumatic benign
fibrosis of the bile ducts causing thickening of the wall with consequent narrowing
of the lumen. In recent years considerable controversy has arisen over the criteria to
be used in diagnosis. The most stringent are those of Myers and his colleagues4 who
list the following essential features: (1) progressive obstructive jaundice, (2) absence
of biliary calculi, (3) no prior biliary surgery, (4) generalised thickening of the walls
of the bile ducts, (5) the exclusion of cholangiocarcinoma by a long follow-up
period, (6) no evidence ofprimary biliary cirrhosis on liver biopsy, (7) the absence of
associated diseases such as ulcerative colitis, Crohn's disease and retroperitoneal
fibrosis. However, others consider that these criteria are too rigidI and may result in
some true cases of sclerosing cholangitis being missed.5' 6 Dilatation of intrahepatic
ducts, which usually occurs above traumatic strictures, is seldom seen in sclerosing
cholangitis.7 Exclusion because of the presence of gallstones may prevent consider-
ation of cases in which stones have formed secondary to sclerosing cholangitis.6
Cholangiocarcinoma may also pose a problem. Duct biopsy has been
recommended6,8 but well differentiated cholangiocarcinoma may have a low degree
of malignancy and it may be difficult to distinguish the histological features from
those of benign cicatrisation. Prolonged survival can also occur in patients with
cholangiocarcinoma while conversely some patients with primary sclerosing
cholangitis die within a few years of the onset of the disease.5' 6
It is generally agreed that patients with ulcerative colitis, retroperitoneal fibrosis
and Riedel's thyroiditis should not be excluded from consideration as these
conditions may be part of the same disease process.5
The criteria used in the twelve patients in this series have been the presence of
diffuse or segmental sclerosis of the bile duct that could not be attributed to gall-
stones or previous biliary surgery, the exclusion of primary biliary cirrhosis by
serological tests and where possible liver biopsy, and of cholangiocarcinoma by a
reasonably long period of follow-up.
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Clinical Features
Ten of our twelve patients were male. The average age at the onset of symptoms
was 42.5 years with a range of 19-69 years. The initial symptom in eight patients was
abdominal pain which in four was typical ofbiliary colic. Two ofthe remaining four
patients experienced a dull ache in the epigastrium and in the other two it was felt in
the right upper quadrant. In three patients the initial symptom was obstructive
jaundice with dark urine and pale stools while one patient experienced only pruritus.
When the diagnosis ofprimary sclerosing cholangitis was confirmed, eleven patients
had obstructive jaundice and in four of these the liver was slightly enlarged. Eight
patients had pruritis, three had diarrhoea and in two weight loss was a major
symptom.
In five patients a diagnosis of ulcerative colitis had been made on the sigmoido-
scopic, radiological and histological findings four to ten years before the symptoms
of sclerosing cholangitis commenced. One patient suffered from Raynaud's
phenomenon and another was diabetic. One patient had several attacks of acute
pancreatitis during the ten years prior to the diagnosis of sclerosing cholangitis and
required drainage of a pseudocyst. One patient had a cholecystectomy four years
before the diagnosis ofprimary sclerosing cholangitis was made. No gall stones were
found but the operative cholangiogram showed slightly irregular extrahepatic ducts.
One patient had a cholecystostomy when definite evidence of primary sclerosing
cholangitis was demonstrated by the operative cholangiogram. One patient had
required a laparotomy and cholecystostomy for a biliary leak following a diagnostic
percutaneous needle liver biopsy.
One patient had a sister with ulcerative colitis, the father of another had
pernicious anaemia and the mother of a third had diabetes mellitus.
Laboratory Investigations
All patients had a normal haemoglobin (mean 13.3 g), the W.B.C. was elevated in
only three patients and in none was there eosinophilia. Erythrocyte sedimentation
rate was raised in eight patients (mean 45 mm/hour Westergren). Serum bilirubin
was elevated in eleven of the twelve patients (range 8-188 micromols/l; mean 63.3
micromols/l). There were minor increases in AST and ALT in all patients (AST
range 44-173 U/A; mean 97 U/1). However, the predominant biochemical
abnormality was a high serum alkaline phosphatase, present in all but one patient
when first seen, the range being 125-1545 with a mean of 460 units/l (normal range
35-105 units/l).
Initial serum IgG and IgM levels were normal in all seven patients in whom they
were estimated but six patients had elevated IgA levels (range 4.4-5.9 g/l, mean 4.80
g/l). Serum protein electrophoresis showed slightly reduced albumin in two patients,
normal alpha, and gamma globulin levels, minor increases in alpha2 globulin and an
elevated beta globulin level in half the patients. Tests for antinuclear factor, smooth
muscle antibody, antimitochondrial antibody, LE cells and Australia antigen were
negative in all patients. Blood culture was repeatedly positive in one patient with
recurrent cholangitis in whom Klebsiella were grown on culture.
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duct obstruction with chronic inflammatory cell infiltrates. Some bile ductule
reduplication was noted in two of the biopsies.
Radiology
The diagnosis of primary sclerosing cholangitis was made by percutaneous
transhepatic cholangiography in nine patients, the typical narrowing and beading
with segmental strictures being found. In one patient the diagnosis was made by
ERCP which was unfortunately followed by ascending cholangitis. In the remaining
two patients the lesions were demonstrated by operative cholangiography.
Intravenous cholangiography was attempted in seven patients but only in one was
the biliary tree satisfactorily visualised.
TREATMENT
Surgical Management
In two patients T tube drainage of the common bile duct was carried out prior to
referral for definitive surgery. One patient underwent Longmire's procedure of left
hepaticodochojejunostomy. Four years later a distal splenorenal shunt was
performed for portal hypertension and two years thereafter she required excision of
a cystadenocarcinoma ofthe ovary which caused her death one year later. The other
patient had a hepaticodochojejunostomy (en-Y) and the anastomosis had to be
refashioned four years later. Apart from four bouts ofmild ascending cholangitis he
has remained well on 10 mg of prednisolone daily. A further patient with a localised
stricture of the common bile duct underwent a choledochoduodenostomy. This also
required to be refashioned ten years later and apart from one attack of ascending
cholangitis, he has remained well on 10 mg of prednisolone daily. Portal hyper-
tension developed in four patients, one of whom required a distal splenorenal shunt
for bleeding varices four years after the diagnosis of primary sclerosing cholangitis.
Medical Treatment
Eleven patients were treated with prednisolone, usually beginning with 15-25 mg
per day, the dose then beinggradually reduced to a maintenance level of5-10 mg per
day. Response to steroids was usually good with rapid clinical and biochemical
improvement. One patient was also given azathioprine for a short period. Three
patients received short courses of cholestyramine for pruritus with some
improvement.
Side Effects
Three patients developed back pain due to osteoporosis and one suffered
compression-collapse of a lumbar vertebra. Muscle wasting also occurred in these
three patients. Two patients became hypertensive and one developed diabetes
mellitus. Ascending cholangitis occurred in half of the patients and several had
multiple episodes. In those patients who had bile culture, E coli or Klebsiella were
the offending organisms. Response to treatment with tetracycline, ampicillin or a
cephalosporin was usually rapid.
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There have been four deaths. One patient died of renal failure and severe hepatic
dysfunction four years after the initial diagnosis, one patient died of cirrhosis and
ovarian carcinoma after ten years and another died of liver failure and portal
hypertension after four years. The fourth patient, who had ulcerative colitis,
developed a carcinoma of the colon which was successfully resected but died of an
oat cell carcinoma ofthe lung fouryears after the diagnosis ofsclerosing cholangitis.
The remaining eight patients are alive. Four are symptom-free, three have trouble-
some pruritus and one has a persistent biliary fistula. The period offollow-up ranges
from 1-18 years, the average being 6.2 years.
DISCUSSION
Primary sclerosing cholangitis is a disease, the aetiology of which is at present
unknown. Various causes have been suggested, including bacterial or viral infection,
damage by gallstones and chemical injury by deconjugated bile salts. However the
relative sparing ofthe mucosa casts doubt on these aetiologies and the most accepted
theory at present is a disorder of immunity.5
In common with other series the majority of our patients were male with a wide
age range when first seen.9 The usual presentation in the literature is obstructive
jaundice,6. 8 10 but in our patients abdominal pain was a frequent initial symptom.
The association between sclerosing cholangitis and ulcerative colitis has been widely
recognised3' 6, 8, 11 and sclerosing cholangitis is one of several forms of hepatic
disorder that can occur with inflammatory bowel disease.'2 Recent data suggest that
the prognosis ofpatients with ulcerative colitis and sclerosing cholangitis may not be
as favourable as was originally thought.'3 An association has also been noted with
Crohn's disease,'4 retroperitoneal fibrosis and Riedel's thyroiditis,'5 but none of our
patients had any of these conditions. The ESR was usually increased but few other
haematological disturbances were found in our patients though others have reported
lymphocytosis and eosinophilia.7' 10, 1 Biochemical analysis confirmed the
obstructive nature of the jaundice with grossly elevated alkaline phosphatase levels
being also a constant finding in other series.89, 16 In common with others we found
immunological screening to be negative in our patients although occasionally weakly
positive SMA, AMA and ANF have been reported.9' " Immunological levels in
sclerosing cholangitis are usually normal 7 though raised IgM has been reported.9
Six of our patients had increased IgA; this finding has not previously been noted.
Routine liver biopsy provided only non-specific information and this has also
been the experience of others. Attempts have been made to improve diagnostic
accuracy by staining for copper deposits9 but these also occur in the late stage of
primary biliary cirrhosis.
Several reports have suggested that laparotomy is essential for accurate
diagnosis""6 but percutaneous transhepatic cholangiography using the Chiba needle
is the investigation ofchoice5'9 and displays the beaded appearance ofthe bile ducts,
decreased arborisation and bile duct strictures of varying length.'8 In sclerosing
cholangitis proximal bile duct dilatation rarely occurs unlike traumatic strictures.7
ERCP is also a useful adjunct to diagnosis but, in already obstructed ducts, there is
some risk of precipitating acute cholangitis. Intravenous cholangiography was
unhelpful.
47Treatment of this rare condition is difficult to evaluate as there have been no
controlled trials. Antibiotics have a definite role in treating bouts of ascending
cholangitis and cholestyramine usually relieves pruritus. Most controversy
surrounds the use of steroids. Schwartz and Dale considered steroids to be of
benefit'0 and in 1973 Schwartz reported a satisfactory response in nine out of eleven
cases.'9 Myers and his colleagues4 noted reversal of abnormal radiological findings
but others have observed only temporary remission.' 6, 11, 16 Very few encouraging
results of treatment with azathioprine have been reported20 and occasionally natural
remission of the disease was thought to have occurred.'4 Our experience closely
corresponds to that of Schwartz and a dose of 5-10 mg of prednisolone daily
appears to keep the disease in remission for prolonged periods though careful
monitoring is required to avoid steroid-induced side effects such as osteoporosis.
A variety ofsurgical procedures designed to decompress the biliary tree have been
advocated and some reports have suggested that this is the only effective form of
treatment.6 " Prolonged T tube drainage until there is radiographic evidence of
remission of the disease has been proposed.6 ' For patients with diffuse bile duct
involvement either prolonged decompression using an external T tube or internal
drainage with a T tube following hepaticojejunostomy' have been advised.
Temporary transhepatic biliary drainage has also been used. For patients with
localised strictures considerable benefit has been obtained from choledocho-
duodenostomy or choledochojejunostomy for distal strictures and hepaticojejuno-
stomy with Roux-en-Y for proximal strictures. Our patients who required surgical
by-pass have had encouraging results though the numbers are small. Recently Pitt
and his colleagues have reported an aggressive surgical policy in which they carried
out choledochenteric anastomoses in patients with a major area of extrahepatic
blockage or primary involvement of the extrahepatic ducts. At a mean follow-up of
52 months after surgery thirteen out of seventeen patients were considered to have
had a good result.21
Widely differing prognoses for this condition are given in the literature. Although
Schwartz and Dale reported only one death in their six patients,'0 most authors
conclude that the prognosis is poor.' 5, 6 Recently Thompson and his colleagues22
have suggested that primary sclerosing cholangitis is a heterogenous disease with
four subgroups each with differing prognoses, namely: (1) sclerosing cholangitis
affecting primarily the distal common bile duct, (2) sclerosing cholangitis occurring
soon after an attack of acute necrotising cholangitis, (3) chronic diffuse sclerosing
cholangitis and (4) chronic diffuse sclerosing cholangitis associated with
inflammatory bowel disease. Group 1 seemed to benefit from choledochenteric
anastomosis and to do well. If the patients in Group 2 survived the initial acute
attack, they also seemed to have a good outlook. Eight deaths occurred at a mean of
4.3 years among the 29 patients in Groups 3 and 4. However, there were eleven long-
term survivors. In those patients with ulcerative colitis, colectomy appeared to
confer no benefit on the biliary disease.
In this series eight of the twelve patients are still alive at mean follow-up of 6.2
years and there are six long-term survivors of more than five years. There were two
deaths from liver failure and the other two patients died from ovarian carcinoma
and oat cell carcinoma of the lung respectively. We consider that long-term
48maintenance treatment with prednisolone combined with internal choledochenteric
anastomosis for tight strictures, especially of the distal ducts, has proved
satisfactory.
Ascending cholangitis requires prompt treatment with an appropriate antibiotic
and close monitoring of the dose of steroids is needed in order to minimise side-
effects. There may be a future role for dilatation of localised strictures under
radiological screening and the place ofendoscopic transnasal biliary drainage awaits
evaluation.
SUMMARY
The clinical features, investigation, treatment and prognosis of twelve patients
with primary sclerosing cholangitis are presented. Ten patients were male. The
initial symptom in eight was abdominal pain, sometimes recurrent, and jaundice
developed in all but one of the twelve patients. A raised serum alkaline phosphatase
levelwasthemostconsistent biochemicalabnormality and percutaneous transhepatic
cholangiography showed good evidence of the extent of the changes in the biliary
tree. Eleven patients were treated with prednisolone and three underwent definitive
surgery. Four deaths have occurred in the series; two from liver failure, one from an
ovarian carcinoma and the other from a malignant lung tumour. Of the remaining
eight patients, six have been alive for more than five years. All are receiving a small
maintenance dose of prednisolone.
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